Clinical Trials Browser

Phase 2 × UNKNOWN × Head and Neck Neoplasms × Clear all

NCT04999800 2021-08-11

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03572829 2020-07-15

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Phase 2 Completed

Head and Neck Neoplasms, Vomiting

NCT03744208 2018-11-16

SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms